Why the study?
Are elevated serum chemerin levels associated with the presence of coronary artery disease in patients with metabolic syndrome?
Are elevated serum chemerin levels associated with the presence of coronary artery disease in patients with metabolic syndrome?
Answers are grounded in this paper and cite their sources.
Elevated serum chemerin levels may serve as an independent predictive marker for coronary artery disease in patients with metabolic syndrome.
Elevated serum chemerin levels could be considered as an independent predictive marker of the presence of CAD in patients with MetS.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: